These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22950496)

  • 1. Discovery of lansoprazole and its unique pharmacological properties independent from anti-secretory activity.
    Satoh H
    Curr Pharm Des; 2013; 19(1):67-75. PubMed ID: 22950496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton Pump Inhibitors Prevent Gastric Antral Ulcers Induced by NSAIDs via Activation of Capsaicin-Sensitive Afferent Nerves in Mice.
    Satoh H; Akiba Y; Urushidani T
    Dig Dis Sci; 2020 Sep; 65(9):2580-2594. PubMed ID: 32140944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exacerbation of nonsteroidal anti-inflammatory drug-induced small intestinal lesions by antisecretory drugs in rats: the role of intestinal motility.
    Satoh H; Amagase K; Takeuchi K
    J Pharmacol Exp Ther; 2012 Nov; 343(2):270-7. PubMed ID: 22854201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo protection against indomethacin-induced small intestinal injury by proton pump inhibitors, acid pump antagonists, or indomethacin-phosphatidylcholine.
    Lim YJ; Phan TM; Dial EJ; Graham DY; Lichtenberger LM
    Digestion; 2012; 86(2):171-7. PubMed ID: 22907267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of proton pump inhibitors against indomethacin-induced lesions in the rat small intestine.
    Pozzoli C; Menozzi A; Grandi D; Solenghi E; Ossiprandi MC; Zullian C; Bertini S; Cavestro GM; Coruzzi G
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Jan; 374(4):283-91. PubMed ID: 17151854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a proton pump inhibitor, AG-1749 (lansoprazole), on reflux esophagitis and experimental ulcers in rats.
    Inatomi N; Nagaya H; Takami K; Shino A; Satoh H
    Jpn J Pharmacol; 1991 Apr; 55(4):437-51. PubMed ID: 1886289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of esomeprazole on healing of nonsteroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: Characterization of molecular mechanisms.
    Fornai M; Colucci R; Antonioli L; Awwad O; Ugolini C; Tuccori M; Fulceri F; Natale G; Basolo F; Blandizzi C
    Pharmacol Res; 2011 Jan; 63(1):59-67. PubMed ID: 20969958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
    Howden CW
    Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lansoprazole and omeprazole in the treatment of acid peptic disorders.
    Blum RA
    Am J Health Syst Pharm; 1996 Jun; 53(12):1401-15. PubMed ID: 8781686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recommendation for the prevention and treatment of non-steroidal anti-inflammatory drug-induced gastrointestinal ulcers and its complications].
    ;
    Zhonghua Nei Ke Za Zhi; 2017 Jan; 56(1):81-85. PubMed ID: 28056333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C
    Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pharmacokinetic/pharmacodynamic study of proton pump inhibitors, omeprazole and lansoprazole in rats.
    Katashima M; Yamamoto K; Sugiura M; Sawada Y; Iga T
    Drug Metab Dispos; 1995 Jul; 23(7):718-23. PubMed ID: 7587960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lansoprazole. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders.
    Barradell LB; Faulds D; McTavish D
    Drugs; 1992 Aug; 44(2):225-50. PubMed ID: 1382017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacokinetic/pharmacodynamic analysis of proton pump inhibitors omeprazole, lansoprazole and pantoprazole, in humans.
    Katashima M; Yamamoto K; Tokuma Y; Hata T; Sawada Y; Iga T
    Eur J Drug Metab Pharmacokinet; 1998; 23(1):19-26. PubMed ID: 9625268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Proton pump inhibitors, a family of drugs in continuous expansion].
    Pellicano R
    Minerva Gastroenterol Dietol; 2000 Dec; 46(4):231-41. PubMed ID: 19320085
    [No Abstract]   [Full Text] [Related]  

  • 16. A new mechanism for anti-inflammatory actions of proton pump inhibitors--inhibitory effects on neutrophil-endothelial cell interactions.
    Yoshida N; Yoshikawa T; Tanaka Y; Fujita N; Kassai K; Naito Y; Kondo M
    Aliment Pharmacol Ther; 2000 Apr; 14 Suppl 1():74-81. PubMed ID: 10807407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lansoprazole--profile of a new proton pump inhibitor].
    Seifert E
    Leber Magen Darm; 1994 Mar; 24(2):66-8, 71. PubMed ID: 8196467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention by lansoprazole, a proton pump inhibitor, of indomethacin -induced small intestinal ulceration in rats through induction of heme oxygenase-1.
    Yoda Y; Amagase K; Kato S; Tokioka S; Murano M; Kakimoto K; Nishio H; Umegaki E; Takeuchi K; Higuchi K
    J Physiol Pharmacol; 2010 Jun; 61(3):287-94. PubMed ID: 20610858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pump inhibitors exert anti-inflammatory effects and decrease human microglial and monocytic THP-1 cell neurotoxicity.
    Hashioka S; Klegeris A; McGeer PL
    Exp Neurol; 2009 May; 217(1):177-83. PubMed ID: 19232345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study on the activity of lansoprazole, omeprazole and PD-136450 on acidified ethanol- and indomethacin-induced gastric lesions in the rat.
    Chandranath SI; Bastaki SM; Singh J
    Clin Exp Pharmacol Physiol; 2002 Mar; 29(3):173-80. PubMed ID: 11906479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.